Home Search

omqs - search results

If you're not happy with the results, please do another search

Ouch…Omniq (OMQS).

We had fun with this for a good year, doubling after we found it. Adding OmniQ (OMQS) $5.00...
omniq

OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.

Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share. Without disrupting legacy sales - CEO Shai...

OMNIQ (OMQS) to Begin Trading on NASDAQ

100% Here, 100% There, Pretty Soon it all Adds up. Our Sixth Client to Graduate to NASDAQ. Yes, some...
OMNIQ

OMNIQ (OMQS) $10.00, Announces Record $25 Million in New Orders, 100% Growth in AI-Based...

OMNIQ Announces Q4 2020 Revenue, up 12% YoY achieving $13 Million in Q4 Revenue; Growth Accelerates in Q1 2021 with a...
OMNIQ

OmniQ (OMQS) Lands Another $6.6 Million in New Orders.

OMNIQ Receives $6.6 Million in New Orders from a Leading U.S. Supermarket Chain for "Touchless" Real-time Data Collection and Analysis Solutions
OMNIQ

OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.

OMNIQ Corp. Reports Strong Sales of $15.8 Million for Third Quarter of 2020, up 21% Year over Year
OMQS

Adding OmniQ (OMQS) $5.00 to the Watch List.

Artificial Intelligence (AI) Fans Take a Peek. This is our Latest Attempt at...
OMNIQ

OMNIQ (OMQS) Corp. Acquires Eyepax Parking Assets.

OMNIQ Corp. Acquires Eyepax USA's Intellectual Property and Technology to Establish Leadership in Multibillion Dollar Automated Parking Solutions Market

ThinkEquity Investor Conference (NYC), Wednesday October 26th.

ThinkEquity is a boutique investment bank run by experienced professionals that have worked together for over a...

Institutional Analyst, Weekly Newsletter.

- Telehealth Watch List- 2021 Psychedelic Investor Guide out Wednesday.- Report: Ehave Inc (EHVVF) Our Favorite Small Psychedelic Company- Ehave (EHVVF) Announces Inclusion...

Latest article

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...